Pharma IP Circle

A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions

Saturday, October 28, 2017

Tenofovir disoproxil fumarate & Emtricitabine - Denmark

›
On Oct. 26, 2017, the Danish Maritime and Commercial High Court issued a decision rejecting Gilead's motion for preliminary injunction...
Friday, October 27, 2017

Glatiramer acetate - UK

›
On Oct 26, 2017, UK High Court of Justice has issued a decision in favor of Mylan and its European partner Synthon, finding Teva's pat...

Mesalamine - USA

›
On Oct. 24, 2017, Judge Rodney Gilstrap of Eastern district of Texas dismissed Allergan’s suit against Teva & Mylan for alleged infrin...
Thursday, October 26, 2017

Ertapenem – USA

›
On Oct. 26, 2017, Federal circuit affirmed the Delaware court’s decision of obviousness in Invanz® case. Merck Sharp & Dohme Corp....
Tuesday, October 24, 2017

Cyclosporine – USA

›
On Oct. 16, 2017, Judge Bryson of Eastern District of Texas issued an opinion & found Restasis® (Cyclosporine) patents invalid as obvi...

Ethinylestradiol & Etonogestrel - USA

›
On Oct 19, 2017, in a nonprecedential opinion Federal circuit reversed District court of Delaware’s decision on obviousness in NuvaRing ® ...

Dronedarone - USA

›
On Oct. 23, 2017, Court of Delaware issued a trial opinion in Multaq ® case & found asserted patent valid & infringed by ANDA file...
Wednesday, October 18, 2017

Tenofovir disoproxil fumarate & Emtricitabine - Switzerland

›
The Complementary Protection Certificate C00915894 / 01 is based on basic patent EP0915894 B1 . The Swiss SPC covers product “ tenofovir ...

Metaxalone - USA

›
On Oct 17, 2017, by Rule 36 judgment Federal circuit affirmed District court of Maryland’s decision (Sep 27, 2016) of non-infringement of ...
Saturday, October 14, 2017

Naltrexone & Bupropion – USA

›
On Oct. 13, 2017, District court of Delaware issued an opinion & found Contrave® patents valid & infringed by Actavis. Plainti...
‹
›
Home
View web version

Mahendraa

Mahendraa
View my complete profile
Powered by Blogger.